In thiscase report, we want to present a successful anesthetic management of percutaneous nephrolithotomy operation under general anesthesia with rocuronium for the 75-year-old patient with myasthenia gravis that does not require postoperative mechanical ventilation with using sugammadex.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:In thiscase report, we want to present a successful anesthetic management of percutaneous nephrolithotomy operation under general anesthesia with rocuronium for the 75-year-old patient with myasthenia gravis that does not require postoperative mechanical ventilation with using sugammadex.
📊
Key Findings & Data:In thiscase report, we want to present a successful anesthetic management of percutaneous nephrolithotomy operation under general anesthesia with rocuronium for the 75-year-old patient with myasthenia gravis that does not require postoperative mechanical ventilation with using sugammadex.
💡
Conclusion & Impact:In thiscase report, we want to present a successful anesthetic management of percutaneous nephrolithotomy operation under general anesthesia with rocuronium for the 75-year-old patient with myasthenia gravis that does not require postoperative mechanical ventilation with using sugammadex.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
In thiscase report, we want to present a successful anesthetic management of percutaneous nephrolithotomy operation under general anesthesia with rocuronium for the 75-year-old patient with myasthenia gravis that does not require postoperative mechanical ventilation with using sugammadex.
Özet
Bu olgu sunumunda, perkütan nefrolitotomi için roküronyum ile genel anestezi uygulanan miyastenia gravisli 75 yaşındaki hastada sugamadeks ile postoperatif mekanik ventilasyon gerektirmeyen başarılı bir anestezi yönetimini sunmak istedik.
🔖
Cite This Article
KİRMAN, N., KARARSLAN, Ş. A., KILIÇÇIOĞLU, F., KARAMAN, Y., GÖNÜLLÜ, M. (2013). The use of sugammadex ın a patıent wıth myasthenıa gravıs. İzmir Tepecik Eğitim Hastanesi Dergisi, Cilt: 23 - Sayı: 1, 41–43. https://ajindex.com/articles/217156
Basaranoglu G, Erden V, Delatioglu H. Anesthesia of a patient with cured myasthenia gravis. AnesthAnalg 2003; 96: 1842-3.
Unterbuchner C, Fink H, Blobner M. The use of sugammadex in a patient with myasthenia gravis. Anaesthesia 2010;65:302- 5. Osserman KE, Genkins G. Studies in myastheniagravis: Review of a twenty-year experience in over 1200 patients. Mt Sinai J Med 1971;38:497-537.
DeBoer HD, VanEgmond J, Van de Pol F, Bom A, Booij LH. Chemical encapsulation of rocuronium by synthetic cyclodex trin derivatives: reversal of neuromuscular block in anaesthetized Rhesus monkeys. Br J Anaesth2006;96:201-6.
Mekis D, Kamenik M. Remifentanil and high thoracic epi dural anaesthesia: A successful combination for patients with myasthenia gravis undergoing transsternal thymectomy. Eur J Anaesthesiol 2005;22:397-9.
Petrun AM, Mekis D, Kamenik M. Successful use of rocuronium and sugammedex in a patient with myasthenia. Eur J Anaesth 2010;27:917-22. Hunter JM. New neuromuscular blocking drugs. N Engl J Med 1995; 332:1691-9.
Osmer C, Vogele C, Zickmann B, Hempelmann G. Comparative use of muscle relaxants and their reversal in three European countries: a survey in France, Germany and Great Britain. Eur J Anaesthesiol 1996;13:389-99. http://dx.doi.org/ 10.1097/00003643-199607000-00016 PMid:8842663 Booij LH, de Boer HD, van Egmond J. Reversal agents for non depolarizing neuromuscular blockade: reasons for and development of a new concept. Semin Anesth Perioperative Med Pain 2002; 21:92-8.
Bom A, Bradley M, Cameron K, et al. A novel concept of reversing neuromuscularblock: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host. Angew Chem Int Ed Engl 2002;41:266-70.